Page last updated: 2024-11-07

prednisone and Carcinoma, Embryonal

prednisone has been researched along with Carcinoma, Embryonal in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Carcinoma, Embryonal: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mascalchi, M1
Roncaroli, F1
Salvi, F1
Frank, G1

Other Studies

1 other study available for prednisone and Carcinoma, Embryonal

ArticleYear
Transient regression of an intracranial germ cell tumour after intravenous steroid administration: a case report.
    Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 64, Issue:5

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Biopsy; Brain Neoplasms; Carcinoma, Embryonal; Caudate

1998